Abstract
L-Glutamic acid was shown to increase the stability of cells of the HL-60 line of human promyelocyte leukemia to the cytotoxic action of tumor necrosis factor alpha (TNF-α) due to the inhibition of apoptotic and NF-κB-activating cascades induced by this cytokine. At the same time, L-glutamic acid increases the TNF-α-mediated differentiating signal and the accompanying enhancement of the phosphatidylinositol-specific phospholipase C activity. Therefore, it is a promising agent for the reduction of total toxicity and inflammatory processes during treatment with TNF-α.
Similar content being viewed by others
Abbreviations
- FADD:
-
Fas-Associated Death Domain Protein
- FITC:
-
fluorescein isothiocyanate
- IP1–3 :
-
inositol mono-, di-, and triphosphates
- PBS:
-
phosphate-buffered saline
- PI-PLC:
-
phosphatidylinositol-specific phospholipase C
- PIP2 :
-
phosphatidylinositol 4,5-bisphosphate
- PIP5K:
-
4-phosphate-5-kinase
- RIP:
-
TNF-α-Receptor Interacting Protein
- TNF-α:
-
Tumor Necrosis Factor alpha
- TNF-R*:
-
receptor of TNFα
- TRADD:
-
TNF-R1-Associated Death Domain Protein
- TRAF:
-
TNF-Receptor-Associated Factor
REFERENCES
Wickremasinge, R.G. and Hoffbrand, A.V., Blood, 1999, vol. 93, pp. 3587–3600.
James, S.Y., Williams, M.A., Newland, A.C., and Colston, K.W., Gen. Pharmacol., 1999, vol. 32, pp. 143–154.
Cotter, T.G., Fernandes, T.S., Verhaegen, S., and McCarthy, J.M., Immunol. Rev., 1994, vol. 142, pp. 93–112.
Ketley, N.J., Allen, P.D., Kelsey, S.M., and Newland, A.C., Blood, 1997, vol. 90, pp. 4578–4587.
Martin, S.J., Bradley, J.G., and Cotter, T.G., Clin. Exp. Immunol., 1990, vol. 79, pp. 448–453.
Solary, E., Bertrand, R., Kohn, K.W., and Pommier, Y., Blood, 1993, vol. 81, pp. 1359–1368.
Sordet, O., Bettaieb, A., Bruey, J.M., Eymin, B., Droin, N., Ivarsson, M., Garrido, C., and Solary, E., Cell. Death Differ., 1999, vol. 6, pp. 351–361.
Zwelling, L.A., Chan, D., Hinds, M., Mayes, J., Silberman, L.E., and Blick, M., Cancer Res., 1988, vol. 48, pp. 6625–6633.
Kikuchi, H., Iizuka, R., Sugiyama, S., Gon, G., Mori, H., Arai, M., Mizumoto, K., and Imajoh-Ohmi, S., J. Leukocyte Biol., 1996, vol. 60, pp. 778–783.
Wu, Y.L., Jiang, X.R., Allen, P.D., Jia, L., Dronfield, D.M., Newland, A.C., and Kelsey, S.M., Leukocyte Res., 1996, vol. 20, pp. 47–55.
Del Bino, G., Li, X., Traganos, F., and Darzynkiewicz, A., Leukemia, 1994, vol. 8, pp. 281–288.
Vondracek, J., Sheard, M.A., Krejci, P., Minksova, K., Hofmanova, J., and Kozubik, A., J. Leukocyte Biol., 2001, vol. 69, pp. 794–802.
Wajant, H., Pfizenmaier, K., and Scheurich, P., Cell Death Differ., 2003, vol. 10, pp. 45–65.
Kostanyan, I.A., Navolotskaya, E.V., Nurieva, R.I., Astapova, M.V., Dranitsyna, S.M., Zav'yalov, V.P., and Lipkin, V.M., Bioorg. Khim., 1998, vol. 24, pp. 3–9.
Kostanyan, I.A., Nurieva, R.I., Navolotskaya, E.V., Astapova, M.V., Dranitsina, S.M., Bogachuk, A.P., Zav'jalov, V.P., and Lipkin, V.M., Immunol. Lett., 1998, vol. 62, pp. 9–13.
Astapova, M.V., Lipkin, V.M., Arkhipova, M.V., Andreeva, S.G., Dranitsyna, S.M., Merkulova, M.I., Nurieva, R.I., Navolotskaya, E.V., and Kostanyan, I.A., Bioorg. Khim., 1999, vol. 25, pp. 816–820.
Whetton, A.D., Heyworth, C.M., Nicholls, S.E., Evans, C.A., Lord, J.M., Dexter, T.M., and Owen-Linch, P.J., J. Cell Biol., 1994, vol. 125, pp. 651–659.
Nicholls, S.E., Heyworth, C.M., Dexter, T.M., Lord, J.M., Johnson, G.D., and Whetton, A.D., J. Immunol., 1995, vol. 155, pp. 845–853.
Neri, L.M., Martelli, A.M., Colamussi, P., Borgatti, P., Marchisio, M., and Capitani, S., FASEB J., 1999, vol. 13, pp. 2299–2310.
Degterev, A., Boyce, M., and Yuan, J., Oncogene, 2003, vol. 22, pp. 8543–8567.
Gupta, S., J. Clin. Immunol., 2002, vol. 22, pp. 185–194.
Vermeulen, L., Wilde, G.D., Notebaert, S., Berghe, W.V., and Haegeman, G., Biochem. Pharmacol., 2002, vol. 64, pp. 963–970.
Castellino, A.M., Parker, G.J., Boronenkov, I.V., Anderson, R.A., and Chao, M.V., J. Biol. Chem., 1997, vol. 272, pp. 5861–5870.
Taylor, P.C., Peters, A.M., Paleolog, E., Chapman, P.T., Elliott, M.J., McCloskey, R., Feldmann, M., and Maini, R.N., Arthritis Rheum., 2000, vol. 43, pp. 38–47.
Blam, M.E., Stein, R.B., and Lichtenstein, G.R., Am. J. Gastroenterol., 2001, vol. 96, pp. 1977–1997.
Legler, D.F., Micheau, O., Doucey, M.A., Tschopp, J., and Bron, C., Immunity, 2003, vol. 18, pp. 655–664.
Doan, J.E., Windmiller, D.A., and Riches, D.W., J. Immunol., 2004, vol. 172, pp. 7654–7660.
Siegel, R.M., Frederiksen, J.K., Zacharias, D.A., Chan, F.K., Johnson, M., Lynch, D., Tsien, R.Y., and Lenardo, M.J., Science, 2000, vol. 288, pp. 2354–2357.
Wyllie, A.H., Kerr, J.F., and Currie, A.R., Int. Rev. Cytol., 1980, vol. 68, pp. 251–306.
Baek, S.H., Seo, J.K., Chae, C.B., Suh, P.G., and Ryu, S.H., J. Biol. Chem., 1996, vol. 271, pp. 8170–8175.
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Bioorganicheskaya Khimiya, Vol. 31, No. 6, 2005, pp. 602–608.
Original Russian Text Copyright © 2005 by Gibanova, Rakitina, Zhokhov, Pustoshilova, Lipkin, Kostanyan.
Rights and permissions
About this article
Cite this article
Gibanova, N.V., Rakitina, T.V., Zhokhov, S.S. et al. L-Glutamic Acid Modulates the Cytotoxic Effect of Tumor Necrosis Factor on the HL-60 Cell Line. Russ J Bioorg Chem 31, 543–548 (2005). https://doi.org/10.1007/s11171-005-0074-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11171-005-0074-9